{"id":127,"date":"2026-08-03T10:57:08","date_gmt":"2026-08-03T10:57:08","guid":{"rendered":"http:\/\/localhost:8081\/therapeutic-areas\/anti-neoplastic\/"},"modified":"2026-10-07T12:36:34","modified_gmt":"2026-10-07T12:36:34","slug":"anti-neoplastic","status":"publish","type":"page","link":"https:\/\/sudair-playground.growmed.co.uk\/ar\/therapeutic-areas\/anti-neoplastic\/","title":{"rendered":"\u0645\u0636\u0627\u062f\u0627\u062a \u0627\u0644\u0623\u0648\u0631\u0627\u0645"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"127\" class=\"elementor elementor-127\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2f079bf e-con-full elementor-hidden-mobile e-flex e-con e-parent\" data-id=\"2f079bf\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cdb1ccb sud-breadcrumb elementor-widget__width-initial elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-text-editor\" data-id=\"cdb1ccb\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"\/\">Home<\/a> <span aria-hidden=\"true\">\/<\/span> <a href=\"\/therapeutic-areas\/\">Therapeutic Areas<\/a> <span aria-hidden=\"true\">\/<\/span> Anti-Neoplastic<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d712caa sud-eyebrow elementor-widget__width-initial elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-heading\" data-id=\"d712caa\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">Anti-Neoplastic<\/div>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-fda4a67 sud-measure elementor-widget__width-initial elementor-hidden-tablet elementor-hidden-mobile elementor-widget elementor-widget-heading\" data-id=\"fda4a67\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-sud-delay=\"1\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Therapies supporting the treatment of Anti-Neoplastic conditions.<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6465d75 elementor-hidden-desktop elementor-hidden-tablet e-flex e-con-boxed e-con e-parent\" data-id=\"6465d75\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4fd9978 sud-eyebrow elementor-widget__width-initial elementor-widget elementor-widget-heading\" data-id=\"4fd9978\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">Anti-Neoplastic<\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-01d9423 e-con-full sud-section sud-field e-flex e-con e-parent\" data-id=\"01d9423\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-8608364 e-flex e-con-boxed e-con e-child\" data-id=\"8608364\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-8634fce e-con-full e-flex e-con e-child\" data-id=\"8634fce\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f8964fa sud-breadcrumb elementor-widget elementor-widget-text-editor\" data-id=\"f8964fa\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"\/\">Home<\/a> <span aria-hidden=\"true\">\/<\/span> <a href=\"\/therapeutic-areas\/\">Therapeutic Areas<\/a> <span aria-hidden=\"true\">\/<\/span> Anti-Neoplastic<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e19221f sud-eyebrow elementor-widget elementor-widget-heading\" data-id=\"e19221f\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<div class=\"elementor-heading-title elementor-size-default\">Our Portfolio<\/div>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dc1afa1 sud-measure elementor-widget elementor-widget-heading\" data-id=\"dc1afa1\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-sud-delay=\"1\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Products in This Therapeutic Area<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-167aba5 sud-lead sud-measure elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"167aba5\" data-element_type=\"widget\" data-e-type=\"widget\" data-sud-reveal=\"true\" data-sud-delay=\"2\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-aba0592 e-flex e-con-boxed e-con e-parent\" data-id=\"aba0592\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-a7f851a e-con-full e-flex e-con e-child\" data-id=\"a7f851a\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4e46b59 sud-pc-wrap elementor-widget elementor-widget-text-editor\" data-id=\"4e46b59\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<div class=\"sud-pc sud-pc--grouped\" data-productcards><section class=\"sud-pc__group\"><h3 class=\"sud-pc__group-title\"><span class=\"sud-pc__group-mark\" aria-hidden=\"true\"><\/span><span class=\"sud-pc__group-name\">Hematology<\/span><\/h3><ul class=\"sud-pc__grid\"><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-imalar-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-imalar-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-imalar.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Imalar&reg;<\/h4><p class=\"sud-pc__sub\">Imatinib<\/p><p class=\"sud-pc__strength\">100 mg \u00b7 400 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-0\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-0\"><span class=\"screen-reader-text\">Show more about Imalar&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-0\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Imalar&reg;<\/p><p class=\"sud-pc__line\">Imalar\u00ae (Imatinib) 100 mg &amp; 400 mg film-coated tablets are indicated for the treatment of CML, Ph+ ALL, MDS\/MPD, and HES\/CEL.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-azacitidine-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-azacitidine-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-azacitidine-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Azacitidine SPC&reg;<\/h4><p class=\"sud-pc__sub\">Azacitidine<\/p><p class=\"sud-pc__strength\">100 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-1\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-1\"><span class=\"screen-reader-text\">Show more about Azacitidine SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-1\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Azacitidine SPC&reg;<\/p><p class=\"sud-pc__line\">Azacitidine SPC\u00ae (Azacitidine) 100 mg powder for solution for injection is indicated for the treatment of MDS and AML in adults ineligible for stem cell transplantation.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-ensutine-300x205.webp\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-ensutine-300x205.webp 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-ensutine.webp 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Ensutine&reg;<\/h4><p class=\"sud-pc__sub\">Bendamustine Hydrochloride<\/p><p class=\"sud-pc__strength\">180 mg\/4 mL<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-2\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-2\"><span class=\"screen-reader-text\">Show more about Ensutine&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-2\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Ensutine&reg;<\/p><p class=\"sud-pc__line\">Ensutine\u00ae (Bendamustine Hydrochloride) 180 mg\/4 mL concentrate for solution for infusion is indicated for the treatment of Chronic Lymphocytic Leukaemia (CLL).<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cekea-300x205.webp\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cekea-300x205.webp 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cekea.webp 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">CEKEA&reg;<\/h4><p class=\"sud-pc__sub\">Hydroxyurea [Hydroxycarbamide]<\/p><p class=\"sud-pc__strength\">200 mg \u00b7 500 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-3\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-3\"><span class=\"screen-reader-text\">Show more about CEKEA&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-3\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About CEKEA&reg;<\/p><p class=\"sud-pc__line\">CEKEA\u00ae (Hydroxyurea [Hydroxycarbamide]) is indicated for the treatment of chronic myeloid leukemia (CML) and cervical cancer. Available in 200 mg and 500 mg capsules.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-otrasa-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-otrasa-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-otrasa.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Otrasa&reg;<\/h4><p class=\"sud-pc__sub\">Dasatinib<\/p><p class=\"sud-pc__strength\">50 mg \u00b7 70 mg \u00b7 100 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-4\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-4\"><span class=\"screen-reader-text\">Show more about Otrasa&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-4\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Otrasa&reg;<\/p><p class=\"sud-pc__line\">Otrasa\u00ae (Dasatinib) is indicated for the treatment of chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and pediatric patients. Available as 50 mg, 70 mg, and 100 mg film-coated tablets.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-carfilzomib-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-carfilzomib-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-carfilzomib-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Carfilzomib SPC&reg;<\/h4><p class=\"sud-pc__sub\">Carfilzomib<\/p><p class=\"sud-pc__strength\">60 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-5\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-5\"><span class=\"screen-reader-text\">Show more about Carfilzomib SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-5\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Carfilzomib SPC&reg;<\/p><p class=\"sud-pc__line\">Carfilzomib SPC\u00ae (Carfilzomib) is indicated for the treatment of multiple myeloma in adults who have received at least one prior therapy. Available as a 60 mg vial for injection.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-bortezomib-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-bortezomib-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-bortezomib-spc.png 704w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Bortezomib SPC&reg;<\/h4><p class=\"sud-pc__sub\">Bortezomib<\/p><p class=\"sud-pc__strength\">3.5 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-6\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-6\"><span class=\"screen-reader-text\">Show more about Bortezomib SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-6\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Bortezomib SPC&reg;<\/p><p class=\"sud-pc__line\">Bortezomib SPC\u00ae (Bortezomib) is indicated for the treatment of multiple myeloma (MM). Available as a 3.5 mg powder for solution for injection.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pomalidomide-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pomalidomide-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pomalidomide-spc.png 704w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Pomalidomide SPC&reg;<\/h4><p class=\"sud-pc__sub\">Pomalidomide<\/p><p class=\"sud-pc__strength\">1 mg \u00b7 2 mg \u00b7 3 mg \u00b7 4 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-7\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-7\"><span class=\"screen-reader-text\">Show more about Pomalidomide SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-7\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Pomalidomide SPC&reg;<\/p><p class=\"sud-pc__line\">Pomalidomide SPC\u00ae (Pomalidomide) is indicated for the treatment of relapsed or refractory multiple myeloma in adults, in combination with other therapeutic agents. Available as 1 mg, 2 mg, 3 mg, and 4 mg capsules.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-lenalidomide-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-lenalidomide-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-lenalidomide-spc.png 704w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Lenalidomide SPC&reg;<\/h4><p class=\"sud-pc__sub\">Lenalidomide<\/p><p class=\"sud-pc__strength\">5 mg \u00b7 10 mg \u00b7 15 mg \u00b7 20 mg \u00b7 25 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-8\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-8\"><span class=\"screen-reader-text\">Show more about Lenalidomide SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-8\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Lenalidomide SPC&reg;<\/p><p class=\"sud-pc__line\">Lenalidomide SPC\u00ae (Lenalidomide) is indicated for the treatment of multiple myeloma (MM), myelodysplastic syndrome (MDS), mantle cell lymphoma (MCL), and follicular lymphoma (FL) in adults. Available as 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg capsules.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-deroxi-liposomal-300x205.webp\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-deroxi-liposomal-300x205.webp 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-deroxi-liposomal.webp 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Deroxi liposomal&reg;<\/h4><p class=\"sud-pc__sub\">Doxorubicin Hydrochloride<\/p><p class=\"sud-pc__strength\">2 mg\/mL<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-0-9\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-0-9\"><span class=\"screen-reader-text\">Show more about Deroxi liposomal&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-0-9\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Deroxi liposomal&reg;<\/p><p class=\"sud-pc__line\">Deroxi Liposomal\u00ae (Doxorubicin Hydrochloride) is indicated for the treatment of breast cancer, ovarian cancer, multiple myeloma, and Kaposi\u2019s sarcoma. Available as a 2 mg\/mL concentrate for solution for infusion.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><\/ul><\/section><section class=\"sud-pc__group\"><h3 class=\"sud-pc__group-title\"><span class=\"sud-pc__group-mark\" aria-hidden=\"true\"><\/span><span class=\"sud-pc__group-name\">Solid Tumors<\/span><\/h3><ul class=\"sud-pc__grid\"><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-fulvestrant-spc-300x205.webp\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-fulvestrant-spc-300x205.webp 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-fulvestrant-spc.webp 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Fulvestrant SPC&reg;<\/h4><p class=\"sud-pc__sub\">Fulvestrant<\/p><p class=\"sud-pc__strength\">250 mg\/5 mL<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-0\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-0\"><span class=\"screen-reader-text\">Show more about Fulvestrant SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-0\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Fulvestrant SPC&reg;<\/p><p class=\"sud-pc__line\">Fulvestrant SPC\u00ae (fulvestrant) is indicated for the treatment of hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer, either alone or in combination with palbociclib. Available as a 250 mg\/5 mL pre-filled syringe.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-docetaxel-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-docetaxel-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-docetaxel-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Docetaxel SPC&reg;<\/h4><p class=\"sud-pc__sub\">Docetaxel<\/p><p class=\"sud-pc__strength\">80 mg\/4 mL<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-1\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-1\"><span class=\"screen-reader-text\">Show more about Docetaxel SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-1\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Docetaxel SPC&reg;<\/p><p class=\"sud-pc__line\">Docetaxel SPC\u00ae (Docetaxel) is indicated for the treatment of early and advanced breast cancer. Available as an 80 mg\/4 mL vial for injection.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-capecitabine-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-capecitabine-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-capecitabine-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Capecitabine SPC&reg;<\/h4><p class=\"sud-pc__sub\">Capecitabine<\/p><p class=\"sud-pc__strength\">150 mg \u00b7 500 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-2\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-2\"><span class=\"screen-reader-text\">Show more about Capecitabine SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-2\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Capecitabine SPC&reg;<\/p><p class=\"sud-pc__line\">Capecitabine SPC\u00ae (Capecitabine) is indicated for the treatment of colon, rectal, gastric, and breast cancers. Available as 150 mg and 500 mg film-coated tablets.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pemetrexed-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pemetrexed-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-pemetrexed-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Pemetrexed SPC&reg;<\/h4><p class=\"sud-pc__sub\">Pemetrexed<\/p><p class=\"sud-pc__strength\">500 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-4\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-4\"><span class=\"screen-reader-text\">Show more about Pemetrexed SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-4\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Pemetrexed SPC&reg;<\/p><p class=\"sud-pc__line\">Pemetrexed SPC\u00ae (Pemetrexed) is indicated for the treatment of malignant pleural mesothelioma and advanced non-small cell lung cancer (NSCLC). Available as a 500 mg concentrate for solution for infusion.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cabazitaxel-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cabazitaxel-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-cabazitaxel-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Cabazitaxel SPC&reg;<\/h4><p class=\"sud-pc__sub\">Cabazitaxel<\/p><p class=\"sud-pc__strength\">60 mg\/1.5 mL<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-5\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-5\"><span class=\"screen-reader-text\">Show more about Cabazitaxel SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-5\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Cabazitaxel SPC&reg;<\/p><p class=\"sud-pc__line\">Cabazitaxel SPC\u00ae (Cabazitaxel) is indicated for the treatment of advanced prostate cancer following prior chemotherapy. Available as a 60 mg\/1.5 mL vial for injection.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><li class=\"sud-pc__item\"><article class=\"sud-pc__card\"><div class=\"sud-pc__head\"><span class=\"sud-pc__media\"><img loading=\"lazy\" width=\"300\" height=\"205\" src=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-abiraterone-acetate-spc-300x205.png\" class=\"sud-pc__img\" alt=\"\" loading=\"lazy\" decoding=\"async\" srcset=\"https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-abiraterone-acetate-spc-300x205.png 300w, https:\/\/sudair-playground.growmed.co.uk\/wp-content\/uploads\/2026\/08\/sudair-product-anti-neoplastic-abiraterone-acetate-spc.png 352w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/span><div class=\"sud-pc__ident\"><h4 class=\"sud-pc__name\">Abiraterone Acetate SPC&reg;<\/h4><p class=\"sud-pc__sub\">Abiraterone Acetate<\/p><p class=\"sud-pc__strength\">250 mg \u00b7 500 mg<\/p><\/div><button class=\"sud-pc__toggle\" type=\"button\" id=\"sud-pg-1-btn-1-6\" aria-expanded=\"false\" aria-controls=\"sud-pg-1-panel-1-6\"><span class=\"screen-reader-text\">Show more about Abiraterone Acetate SPC&reg;<\/span><span class=\"sud-pc__sign\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"sud-pc__panel\" id=\"sud-pg-1-panel-1-6\" hidden><div class=\"sud-pc__panel-inner\"><p class=\"sud-pc__about\">About Abiraterone Acetate SPC&reg;<\/p><p class=\"sud-pc__line\">Abiraterone Acetate SPC\u00ae (Abiraterone Acetate) is indicated for the treatment of metastatic prostate cancer in adult men. Available as 250 mg and 500 mg film-coated tablets.<\/p><\/div><\/div><span class=\"sud-pc__more\" data-pc-more aria-hidden=\"true\" tabindex=\"-1\">Know More<\/span><\/article><\/li><\/ul><\/section><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home \/ Therapeutic Areas \/ Anti-Neoplastic Anti-Neoplastic Therapies supporting the treatment of Anti-Neoplastic conditions. Anti-Neoplastic Home \/ Therapeutic Areas \/ Anti-Neoplastic Our Portfolio Products in This Therapeutic Area Product information is intended for healthcare professionals. Please refer to the approved prescribing information for full details of indications, dosage and safety. Hematology Imalar&reg; Imatinib 100 mg [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":126,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-127","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/pages\/127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/comments?post=127"}],"version-history":[{"count":0,"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/pages\/127\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/pages\/126"}],"wp:attachment":[{"href":"https:\/\/sudair-playground.growmed.co.uk\/ar\/wp-json\/wp\/v2\/media?parent=127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}